Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.  [electronic resource] 

 -  The Lancet. Infectious diseases  Mar 2011 
 - 171-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(10)70288-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Africa South of the Sahara--epidemiology<br/>Anti-HIV Agents--administration & dosage<br/>Breast Feeding<br/>CD4 Lymphocyte Count<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--drug therapy<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Infectious Disease Transmission, Vertical--prevention & control<br/>Nevirapine--administration & dosage<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Young Adult<br/>Zidovudine--therapeutic use